45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,933
Insurances with rates
0
CPT / HCPCS codes
1,213
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 054 | DRG NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $48,346 | $36,260 | — | — | 0 |
| UMBILICAL VESSEL CATH 3 1/2 FR | UMBILICAL VESSEL CATH 3 1/2 FR | $28,449 | $21,336 | — | — | 0 |
| 871 | DRG SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - | $28,262 | $21,196 | — | — | 0 |
| 682 | DRG RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, | $26,994 | $20,245 | — | — | 0 |
| 208 | DRG RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | $26,670 | $20,003 | — | — | 0 |
| 187 | DRG PLEURAL EFFUSION WITH COMPLICATION OR COMORBIDITY (CC) | $22,983 | $17,237 | — | — | 0 |
| 291 | DRG HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, | $22,899 | $17,174 | — | — | 0 |
| J2997 | ALTEPLASE RECOMBINANT | $21,121 | $15,841 | — | — | 0 |
| 50242-0085-27 | alteplase 100 mg IV Inj [WLMH] | $21,121 | $21,121 | — | — | 0 |
| 27446 | Arthroplasty Arthroscopy Knee | $19,854 | $14,890 | — | — | 0 |
| 309 | DRG CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | $19,716 | $14,787 | — | — | 0 |
| 095 | DRG BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | $19,590 | $14,692 | — | — | 0 |
| 812 | DRG RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALEN | $19,035 | $14,276 | — | — | 0 |
| 193 | DRG SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVAL | $18,862 | $14,146 | — | — | 0 |
| 038 | DRG EXTRACRANIAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | $18,540 | $13,905 | — | — | 0 |
| 641 | DRG MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLIC | $17,959 | $13,469 | — | — | 0 |
| 50242-0120-47 | tenecteplase 50 mg Pow [WLMH] | $16,627 | $16,627 | — | — | 0 |
| J9217 | LEUPROLIDE ACETATE SUSPNSION | $16,476 | $12,357 | — | — | 0 |
| 177 | DRG RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $16,248 | $12,186 | — | — | 0 |
| 50242-0120-01 | tenecteplase 50 mg Kit [WLMH] | $16,143 | $16,143 | — | — | 0 |
| 068 | DRG NONSPECIFIC CVA AND PRECEREBRAL OCCLUSION WITHOUT INFARCTION WITHOUT MAJOR COMPLICATION OR COMOR | $15,793 | $11,845 | — | — | 0 |
| 391 | DRG ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR CO | $15,504 | $11,628 | — | — | 0 |
| 094 | DRG BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (M | $14,917 | $11,188 | — | — | 0 |
| 560 | DRG AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) - | $13,485 | $10,114 | — | — | 0 |
| 00074-3346-03 | leuprolide 22.5 mg/3 months Intramuscular Kit [WLMH] | $13,349 | $13,349 | — | — | 0 |
| 190 | DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE | $13,195 | $9,896 | — | — | 0 |
| 638 | DRG DIABETES WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUT | $13,166 | $9,874 | — | — | 0 |
| 056 | DRG DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $13,002 | $9,751 | — | — | 0 |
| 191 | DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVA | $12,644 | $9,483 | — | — | 0 |
| 153 | DRG OTITIS MEDIA AND URI WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $11,500 | $8,625 | — | — | 0 |
| 683 | DRG RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALIT | $11,287 | $8,465 | — | — | 0 |
| 603 | DRG CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, | $9,632 | $7,224 | — | — | 0 |
| 065 | INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HO | $9,430 | $7,073 | — | — | 0 |
| 49320 | Laparoscopy Diagnostic | $9,192 | $6,894 | — | — | 0 |
| 060 | DRG MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICA | $9,106 | $6,830 | — | — | 0 |
| 069 | DRG TRANSIENT ISCHEMIA | $8,417 | $6,313 | — | — | 0 |
| 388 | DRG G.I. OBSTRUCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $8,224 | $6,168 | — | — | 0 |
| 00074-2282-03 | leuprolide 11.25 mg/mth IM Inj, ER [WLMH] | $8,155 | $8,155 | — | — | 0 |
| 47562 | 47562 Laparoscopy, surgical cholecystectomy | $7,443 | $5,582 | — | — | 0 |
| 49650 | 49650 Laparoscopy, surgical repair initial inguinal hernia | $7,443 | $5,582 | — | — | 0 |
| 283 | DRG ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $7,321 | $5,491 | — | — | 0 |
| 42440 | 42440 Excision of submandibular (submaxillary) gland; | $7,273 | $5,454 | — | — | 0 |
| 42830 | Adenoidectomy | $7,273 | $5,454 | — | — | 0 |
| 200 | DRG PNEUMOTHORAX WITH COMPLICATION OR COMORBIDITY (CC) | $7,236 | $5,427 | — | — | 0 |
| 389 | DRG G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | $7,081 | $5,311 | — | — | 0 |
| 45990 | 45990 Anorectal exam, surgical, requiring anesthesia, diagnostic | $7,033 | $5,274 | — | — | 0 |
| 280 | DRG ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $6,620 | $4,965 | — | — | 0 |
| 54520 | 54520-Excision procedure on the testis | $6,411 | $4,808 | — | — | 0 |
| 440 | DRG DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICAT | $6,397 | $4,798 | — | — | 0 |
| 26530 | Arthroplasty Finger | $6,370 | $4,777 | — | — | 0 |
Showing top 50 of 2,933 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.